Inventor
ROBERT HILGRAF
Inventor
US
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes36%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07DHeterocyclic compounds27%
C07BGeneral methods of organic chemistry9%
PatentTitleYear
12,129,237Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith202411,633,415Compounds and methods useful for treating or preventing cancers202311,325,890Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith202211,241,430Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their use2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2024Patents assigned to SIGNAL PHARM LLC (3)· patent assignee history
2022–2024Based in US· patent location history
2023Patents assigned to BROAD INST INC (1)· patent assignee history
2023Patents assigned to DANA FARBER CANCER INST INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SIGNAL PHARM LLC | 3 | 2022–2024 |
| BROAD INST INC | 1 | 2023 |
| DANA FARBER CANCER INST INC | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 4 | 2022–2024 |